NORTHERN TRUST CORP - CANDEL THERAPEUTICS INC ownership

CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 21 filers reported holding CANDEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CANDEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,048
-27.0%
19,6170.0%0.00%
Q2 2023$24,717
-6.7%
19,6170.0%0.00%
Q1 2023$26,483
+2.2%
19,617
+35.4%
0.00%
Q4 2022$25,925
-42.4%
14,4830.0%0.00%
Q3 2022$45,000
-4.3%
14,4830.0%0.00%
Q2 2022$47,000
-30.9%
14,483
+7.6%
0.00%
Q1 2022$68,000
-35.2%
13,4550.0%0.00%
Q4 2021$105,00013,4550.00%
Other shareholders
CANDEL THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Northpond Ventures, LLC 1,935,215$6,077,0004.26%
Sands Capital Ventures, LLC 811,737$2,549,0000.74%
Empirical Asset Management, LLC 12,000$38,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,700$417,0000.01%
Point72 Asset Management, L.P. 403,131$1,266,0000.01%
FRANKLIN RESOURCES INC 1,125,000$3,533,0000.00%
WELLS FARGO & COMPANY/MN 96$00.00%
NORTHERN TRUST CORP 14,483$45,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 128,846$404,0000.00%
View complete list of CANDEL THERAPEUTICS INC shareholders